The goal of this project is to identify cellular defects that are caused by mutations in genes linked to Autism spectrum disorders (ASD), using the C. elegans neuromuscular junction as a model. In particular, we will test two prominent models for pathophysiological mechanisms in ASD. First, we test the idea that ASD linked genes play a direct role in regulating activity induced gene expression. Second, we will determine if ASD linked genes alter the synaptic targeting of GABAA receptors, thereby altering inhibitory synaptic strength. A critical feature of the genetics of ASD is that mutations conferring risk are nearly always heterozygous in affected individuals, implying that the majority of ASD linked genes are dose sensitive. Thus, we will ask if activity-induced gene expression and synaptic targeting of GABAA receptors are sensitive to copy number variations in ASD linked genes. In addition to testing their potential importance in the pathophysiology of ASD, our Aims address basic mechanisms controlling nervous system development and function.

Public Health Relevance

This proposal describes a coherent set of genetic, molecular, and biophysical experiments to determine how mutations linked to Autism alter gene expression and inhibitory synaptic transmission. These experiments may uncover cellular mechanisms that contribute to the developmental and cognitive delays occurring in Autism and other psychiatric disorders.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS032196-24
Application #
9134220
Study Section
Synapses, Cytoskeleton and Trafficking Study Section (SYN)
Program Officer
Mamounas, Laura
Project Start
1993-07-01
Project End
2020-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
24
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
Pym, Edward; Sasidharan, Nikhil; Thompson-Peer, Katherine L et al. (2017) Shank is a dose-dependent regulator of Cav1 calcium current and CREB target expression. Elife 6:
Tong, Xia-Jing; López-Soto, Eduardo Javier; Li, Lei et al. (2017) Retrograde Synaptic Inhibition Is Mediated by ?-Neurexin Binding to the ?2? Subunits of N-Type Calcium Channels. Neuron 95:326-340.e5
Tong, Xia-Jing; Hu, Zhitao; Liu, Yu et al. (2015) A network of autism linked genes stabilizes two pools of synaptic GABA(A) receptors. Elife 4:e09648
Hu, Zhitao; Tong, Xia-Jing; Kaplan, Joshua M (2013) UNC-13L, UNC-13S, and Tomosyn form a protein code for fast and slow neurotransmitter release in Caenorhabditis elegans. Elife 2:e00967
Hu, Zhitao; Hom, Sabrina; Kudze, Tambudzai et al. (2012) Neurexin and neuroligin mediate retrograde synaptic inhibition in C. elegans. Science 337:980-4
Thompson-Peer, Katherine L; Bai, Jihong; Hu, Zhitao et al. (2012) HBL-1 patterns synaptic remodeling in C. elegans. Neuron 73:453-65
Babu, Kavita; Hu, Zhitao; Chien, Shih-Chieh et al. (2011) The immunoglobulin super family protein RIG-3 prevents synaptic potentiation and regulates Wnt signaling. Neuron 71:103-16
Simon, David J; Madison, Jon M; Conery, Annie L et al. (2008) The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell 133:903-15
Chun, Denise K; McEwen, Jason M; Burbea, Michelle et al. (2008) UNC-108/Rab2 regulates postendocytic trafficking in Caenorhabditis elegans. Mol Biol Cell 19:2682-95
Juo, Peter; Harbaugh, Tom; Garriga, Gian et al. (2007) CDK-5 regulates the abundance of GLR-1 glutamate receptors in the ventral cord of Caenorhabditis elegans. Mol Biol Cell 18:3883-93

Showing the most recent 10 out of 22 publications